Moreover, the high expression of PTPN2 promotes the infiltration of PAAD immune cells and is positively correlated with immune checkpoints expression, suggesting that patients with high expression of PTPN2 could respond better to immune checkpoint blocking therapy. The gene discussed is PTPN2; the disease is pancreatic adenocarcinoma.